AJP - Heart Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (September 2, 2004). doi:10.1152/ajpheart.00453.2004
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
288/1/H328    most recent
00453.2004v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (35)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by DAS, S.
Right arrow Articles by DAS, D. K
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by DAS, S.
Right arrow Articles by DAS, D. K
Submitted on May 25, 2004
Accepted on July 28, 2004

PHARMACOLOGICAL PRECONDITIONING WITH RESVERATROL : A ROLE OF CREB-DEPENDENT BCL-2- SIGNALING VIA ADENOSINE A3 RECEPTOR ACTIVATION

SAMARJIT DAS1, GERALD A CORDIS1, NILANJANA MAULIK1, and DIPAK K DAS1*

1 CARDIOVASCULAR RESEARCH CENTER, UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE, FARMINGTON, CT, USA

* To whom correspondence should be addressed. E-mail: DDAS{at}NEURON.UCHC.EDU.

Recent studies demonstrated that resveratrol, a grape-derived polyphenolic phytoalexin, could pharmacologically precondition (PC) the heart through a nitric oxide (NO)-dependent mechanism. Since, adenosine receptors have been found to play a role in PC, this study examined if adenosine receptors could play any role in resveratrol PC. The rats were randomly assigned to one of the following groups: perfused for 15 min with i) Krebs Ringer bicarbonate (KHB) only ii) KHB containing 10 µM resveratrol; iii) 10 µM resveratrol + 1 µM 8-cyclopentyl-1,3-dimethylxanthine (CPT), adenosine A1 receptor blocker; iv) 10 µM resveratrol + 1 µM 8-(3-chlorostysyl) caffeine (CSC), adenosine A2a receptor blocker; v) 10 µM resveratrol + 1 µM 3-Ethyl-5-benzyl-2-methyl-4-phenylethynyl-6-phenyl-1,4-(±)-dihydropyridine-3,5-dicar-boxylate (MRS 1191), adenosine A3 receptor blocker; and vi) 10 µM resveratrol+3 µM 2-(4-Morpholinyl)-8-phenyl-1(4H)-benzopyran-4-one hydrochloride (LY 294002), a phospho inositol (PI)-3-kinase inhibitor. All hearts were then subjected to 30 min ischemia followed by 2 h reperfusion. The results demonstrated significant cardioprotection with resveratrol as evidenced by improved ventricular recovery, and reduced infarct size and cardiomyocyte apoptosis. CPT and MRS 1191, but not CSC, abrogated the cardioprotective abilities of resveratrol suggesting a role of adenosine A1 and A3 receptors in resveratrol PC. Resveratrol induced the expression of Bcl2, and caused its phosphorylation along with phosphorylation of CREB, Akt and Bad. CPT blocked the phosphorylation of Akt and Bad without affecting CREB, while MRS 1191 blocked phosphorylation of all the compounds including CREB. LY 294002 partially blocked the cardioprotective abilities of resveratrol. The results indicate that resveratrol preconditions the heart through the activation of adenosine A1 and A3 receptors, the former transmitting a survival signal through PI-3-kinase-Akt-Bcl2 signaling pathway, while the latter protects the heart through a CREB-dependent Bcl2 pathway in addition to Akt-Bcl2 pathway. Key Words: Resveratrol, Adenosine A1 and A3 Receptors. Akt, CREB, BAD, BCL2, Apoptosis




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. K. Mohan, M. Khan, S. Wisel, K. Selvendiran, A. Sridhar, C. A. Carnes, B. Bognar, T. Kalai, K. Hideg, and P. Kuppusamy
Cardioprotection by HO-4038, a novel verapamil derivative, targeted against ischemia and reperfusion-mediated acute myocardial infarction
Am J Physiol Heart Circ Physiol, January 1, 2009; 296(1): H140 - H151.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. K. Das and N. Maulik
Cardiac genomic response following preconditioning stimulus
Cardiovasc Res, May 1, 2006; 70(2): 254 - 263.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
D. K. Das and N. Maulik
Resveratrol in cardioprotection: a therapeutic promise of alternative medicine.
Mol. Interv., February 1, 2006; 6(1): 36 - 47.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.